Asset protection
With the race to develop a COVID-19 vaccine in full force, and with Moderna having just published encouraging human trial results, news that Russian spies have been targeting vaccine developers in three countries is enough to make pharma investors extremely nervous.
Reports on Thursday emerged that Russian spies are targeting vaccine developers in the United States, Canada and the UK.
Security agencies from all three countries issued a joint statement saying that while espionage had not disrupted work on a vaccine, Russian hackers have been trying to steal information about vaccine efforts.
More specifically, the agencies are blaming the attacks on a Russian intelligence hacking group called “APT29” (aka “Cozy Bear” or “the Dukes”), which was also linked to the 2016 attacks on the Democratic National Committee.
“Throughout 2020, APT29 has targeted various organisations involved in COVID-19 vaccine development in Canada, the United States and the United Kingdom, highly likely with the intention of stealing information and intellectual property relating to the development and testing of COVID-19 vaccines,” agencies said in a warning.
The agencies said the attacks were also directed at the energy industry.
According to the UK’s NCSC security agency, the group “almost certainly operate as part of Russian intelligence services”–an assessment that is supported by the U.S. Department for Homeland Security (DHS), and other Canadian and U.S. agencies.
“APT29’s campaign of malicious activity is ongoing, predominantly against government, diplomatic, think-tank, healthcare and energy targets to steal valuable intellectual property,” the NCSC said…CLICK for complete article
Bullish Moves
Yesterday, the market broke out of its consolidation range that we have been discussing over the past several weeks. Such is undeniably bullish and sets the market up for a test of “all-time” highs.
However, while we did get a bit of “exuberance” yesterday, there was still considerable weakness beneath the overall market. As noted this weekend, the month of July has continued to perform as expected and has provided the seasonal lift to stocks.
“In the short-term, the bulls remain in charge currently, and as such, we must be mindful of those trends. Also, the month of July tends to be one of the better performing months of the year.”
Paul Gill, CEO of Lomiko Metals and Lomiko Technologies shares with Mike some of the critical (and scarce) metal markets that will be key to supporting the green technology revolutions – and why $1500 Telsa shares Do make sense!
The big money center banks got second-quarter earnings season rolling last week, but hundreds more reports are coming this week. In fact, the financial services sector is nowhere near done with second-quarter earnings as dozens of asset managers, credit card issuers and regional banks will step into the earnings confessional this week.
For traders looking for other industries and sectors with earnings catalysts this week, they’re in luck because opportunities abound. Of course, plenty of exchange-traded funds will be worth tapping into this week, too.
Here are three ETFs that will be stepping into the earnings limelight in a big way this week.
U.S. Global Jets ETF (JETS)
The U.S. Global Jets ETF enters airlines earnings season in a tenuous sport. Amid a resurgence of coronavirus cases, the lone ETF dedicated to this industry is down 9% over the past month. Undoubtedly, JETS will be tested this week.
JetBlue gets things going on Tuesday with United Airlines Holdings following on Wednesday. On Thursday, American Airlines and Southwest report. Those four stocks combine for nearly a third of the JETS roster.
Some smaller JETS components also report throughout the week….CLICK for complete article